Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Inmaculada Ruiz de Mena"'
Autor:
Alfredo Carrato, Roberto Pazo-Cid, Teresa Macarulla, Javier Gallego, Paula Jiménez-Fonseca, Fernando Rivera, Maria Teresa Cano, Mercedes Rodríguez Garrote, Carles Pericay, Inmaculada Diaz, Laura Layos, Begoña Graña, Vega Iranzo, Inmaculada Gallego-Jimenez, Rocio Garcia-Carbonero, Maria Alvarez Alejandro, Inmaculada Ruiz de Mena, CARMEN GUILLEN PONCE, Enrique Aranda
Publikováno v:
Journal of Clinical Oncology. 40:4022-4022
4022 Background: Sequential treatment with nab-paclitaxel, gemcitabine followed by oxaliplatin, leucovorin and 5-fluorouracil ( nab-P/Gem-mFOLFOX) have shown a good safety profile and clinical activity in metastatic pancreatic ductal adenocarcinoma (
Autor:
Enrique Aranda, Manuel Benavides, Gema Durán Ogalla, Alfredo Carrato, Inma R. de Mena, Mercedes Rodríguez-Garrote, Jose María Vieitez, Laura García Bermejo, Carmen Guillén-Ponce, Alfredo Castillo, Susana Rodríguez, Inmaculada Ruiz de Mena
Publikováno v:
European journal of cancer (Oxford, England : 1990). 139
Background Although occasioned through different mechanisms, the potential neurotoxicity and also haematological toxicity of nab-paclitaxel and oxaliplatin-based chemotherapy regimen were studied in this trial, which aimed to determine the maximum-to
Autor:
José E. Alés-Martínez, Rafael López, Maica Galán, Cristina Grávalos, Francisco Javier Ramos, M.J. Méndez-Vidal, Enrique Aranda, Carlos F. Lopez, Maria Alsina, Josep Tabernero, Jordi Giralt, Pilar García-Alfonso, Bernardo Queralt, Inmaculada Ruiz de Mena, Fernando Rivera, Antonio Antón, Alfredo Carrato
Publikováno v:
Targeted Oncology. 13:69-78
Pre-operative chemoradiotherapy using a 5-fluorouracil (5-FU)/cisplatin backbone is widely used to improve surgical outcomes in locoregional oesophageal cancer patients, despite a non-negligible failure rate. We evaluated intensification of this appr
Autor:
E. Falcó, M. Salgado, Inmaculada Ruiz de Mena, Manuel Benavides, Pilar García-Alfonso, Andrés Muñoz, Amelia López-Ladrón, Rafael López, Javier Sastre, Gema Durán, Auxiliadora Gómez, Clara Montagut, Fernando Rivera, Enrique Aranda
Publikováno v:
The Oncologist
Lessons Learned RAS- or BRAF-mutated metastatic colorectal cancers (mCRCs) progressing after first-line treatment have a poor prognosis. European and U.S. guidelines include the multikinase inhibitor regorafenib as a standard option for second-line t
Autor:
Rafael Garesse, Inmaculada Ruiz de Mena, Belén Bornstein, Miguel Ángel Fernández-Moreno, Laurie S. Kaguni
Publikováno v:
Journal of Biological Chemistry. 274:37321-37328
The structure of the single copy gene encoding the putative housekeeping isoform of Drosophila melanogaster delta-aminolevulinate synthase (ALAS) has been determined. Southern and immunoblot analyses suggest that only the housekeeping isoform of the